LhARA is multidisciplinary & international collaboration that together are developing a proposed research facility that seeks to exploit laser-driven ions in a hybrid acceleration scheme that will deliver a systematic radiation biology programme and will lay the technological foundations for the transformation of proton and ion beam therapy.
The LhARA accelerator uses the target normal sheath acceleration mechanism to generate short, intense bunches of protons at a nominal energy of 15 MeV. These beams will be captured and focused by a series of Gabor plasma lenses, and subsequently accelerated up to 127 MeV in a fixed-field alternating gradient (FFA) accelerator. The accelerator will serve three automated end stations, each capable of highly flexible beam delivery schemes, enabling scientists to understand how the properties of proton and ion beam play a role in determining biological outcomes during particle beam therapy.
LhARA is in an R&D phase of activity in which we are developing several accelerator technologies to support our initiative, as well as conducting radiobiology experiments in the Proof-of-Principle for LhARA and Radiobiology (PoPLaR) programme that is studying the effects of laser-driven ions on biological tissue samples. In this seminar, an overview of LhARA will be presented, including the LhARA initiative, the LhARA accelerator, its novel technologies, the expected performance, and an overview of the PoPLaR experiments.